Published in Gene Therapy Weekly, May 15th, 2003
The focus of the collaboration will be genes relating to eye diseases. No financial terms were disclosed.
"Our research focuses on the elucidation of the pathophysiology of ocular neuropathies, such as glaucoma, by targeting genes that are known to be implicated in these diseases," commented professor Bernd Wissinger, PhD, Group Leader at the Molecular Genetics Laboratory of the Tuebingen...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly